Cancer chemoprevention: lessons learned and future directions

Por Brenner, D E, Gescher, A J
Publicado em 2005

Lack of effect of treatment with human recombinant-tumour necrosis factor (HrTNF) on the binding of quinidine to alpha 1-acid glycoprotein (AGP).

Por Barnett, J A, Brenner, D E, Creaven, P J, Lalka, D
Publicado em 1989

An evaluation of hepatic extraction and clearance of doxorubicin.

Por August, D. A., Verma, N., Vaertan, M. A., Shah, R., Brenner, D. E.
Publicado em 1995

Clinical and economic impact of multiple gated acquisition scan monitoring during anthracycline therapy

Por Shureiqi, I, Cantor, S B, Lippman, S M, Brenner, D E, Chernew, M E, Fendrick, A M
Publicado em 2002

Doxorubicin cardiotoxicity may be caused by its metabolite, doxorubicinol.

Por Olson, R D, Mushlin, P S, Brenner, D E, Fleischer, S, Cusack, B J, Chang, B K, Boucek, R J
Publicado em 1988

A phase II study of the efficacy of diamminedichloroplatinum (cisplatin) for the control of locally recurrent and intransit malignant melanoma of the extremities using tourniquet o...

Por Bland, K I, Kimura, A K, Brenner, D E, Basinger, M A, Hirsch, M, Hawkins, I F, Pierson, K K, Copeland, E M
Publicado em 1989

A phase I/II pharmacokinetic and pharmacogenomic study of calcitriol in combination with cisplatin and docetaxel in advanced non-small-cell lung cancer

Por Ramnath, N., Daignault-Newton, S., Dy, G. K., Muindi, J. R., Adjei, A., Elingrod, V. L., Kalemkerian, G. P., Cease, K. B., Stella, P. J., Brenner, D. E., Troeschel, S., Johnson, C. S., Trump, D. L.
Publicado em 2013